Neuberger Berman Group LLC Ascendis Pharma A/S Transaction History

Neuberger Berman Group LLC

$123 Billion
Q3 2024

A detailed history of Neuberger Berman Group LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Neuberger Berman Group LLC holds 39,762 shares of ASND stock, worth $5.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,762

Previous 30,296 31.25%

Holding current value

$5.16 Million

Previous $4.13 Million 43.74%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$113.0 - $153.43 $1.07 Million - $1.45 Million	9,466 Added 31.25%	39,762 $5.94 Million
Q2 2024 Aug 13, 2024	BUY	$121.07 - $153.67 $3.67 Million - $4.66 Million	30,296 New	30,296 $4.13 Million
Q2 2021 Aug 13, 2021	SELL	$121.62 - $145.29 $23.2 Million - $27.7 Million	-190,900 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$124.92 - $173.33 $7.55 Million - $10.5 Million	60,400 Added 46.28%	190,900 $24.6 Million
Q4 2020 Feb 10, 2021	BUY	$151.2 - $182.76 $378,000 - $456,900	2,500 Added 1.95%	130,500 $21.8 Million
Q3 2020 Nov 12, 2020	BUY	$134.29 - $154.32 $2.95 Million - $3.4 Million	22,000 Added 20.75%	128,000 $19.8 Million
Q2 2020 Aug 13, 2020	BUY	$110.87 - $156.01 $5.16 Million - $7.25 Million	46,500 Added 78.15%	106,000 $15.7 Million
Q1 2020 May 14, 2020	SELL	$97.01 - $145.11 $501,444 - $750,073	-5,169 Reduced 7.99%	59,500 $6.7 Million
Q4 2019 Feb 12, 2020	BUY	$91.45 - $139.12 $5.91 Million - $9 Million	64,669 New	64,669 $9 Million
Q2 2018 Aug 13, 2018	SELL	$58.55 - $73.92 $819,700 - $1.03 Million	-14,000 Closed	0 $0
Q1 2018 May 08, 2018	BUY	$38.98 - $68.04 $545,720 - $952,560	14,000 New	14,000 $916,000

Others Institutions Holding ASND

# of Institutions

243

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.24B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Ascendis Pharma A/S Transaction History